PROBLEMS IN THE THERAPY OF AXIAL SPONDYLOARTHRITIS IN THE PROCEEDINGS OF THE EULAR CONGRESS 2015 (ROME, 10–13 JUNE 2015)

The Congress considered the issues pertinent  to the latest approaches to therapy for axial spondyloarthritis  (axSpA), as well as the problems associated with a search for axSpA-modifying anti-rheumatic drugs. Reports on the results of therapy with nonsteroidal  anti-inflammatory drugs and biologic...

Full description

Bibliographic Details
Main Authors: O. A. Rumyantseva, Sh. F. Erdes
Format: Article
Language:Russian
Published: IMA PRESS LLC 2016-09-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/2259
_version_ 1797862725527797760
author O. A. Rumyantseva
Sh. F. Erdes
author_facet O. A. Rumyantseva
Sh. F. Erdes
author_sort O. A. Rumyantseva
collection DOAJ
description The Congress considered the issues pertinent  to the latest approaches to therapy for axial spondyloarthritis  (axSpA), as well as the problems associated with a search for axSpA-modifying anti-rheumatic drugs. Reports on the results of therapy with nonsteroidal  anti-inflammatory drugs and biological agents (tumor necrosis factor-α  and interleukin 17/23 inhibitors) were of the most relevance.
first_indexed 2024-04-09T22:24:12Z
format Article
id doaj.art-7221dec6e4a24d4fa921372c1deac92b
institution Directory Open Access Journal
issn 1995-4484
1995-4492
language Russian
last_indexed 2024-04-09T22:24:12Z
publishDate 2016-09-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj.art-7221dec6e4a24d4fa921372c1deac92b2023-03-22T13:45:51ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922016-09-01541S838610.14412/1995-4484-2016-1S-83-862127PROBLEMS IN THE THERAPY OF AXIAL SPONDYLOARTHRITIS IN THE PROCEEDINGS OF THE EULAR CONGRESS 2015 (ROME, 10–13 JUNE 2015)O. A. Rumyantseva0Sh. F. Erdes1V.A. Nasonova Research Institute of Rheumatology, MoscowV.A. Nasonova Research Institute of Rheumatology, MoscowThe Congress considered the issues pertinent  to the latest approaches to therapy for axial spondyloarthritis  (axSpA), as well as the problems associated with a search for axSpA-modifying anti-rheumatic drugs. Reports on the results of therapy with nonsteroidal  anti-inflammatory drugs and biological agents (tumor necrosis factor-α  and interleukin 17/23 inhibitors) were of the most relevance.https://rsp.mediar-press.net/rsp/article/view/2259axial spondyloarthritisnonsteroidal anti-inflammatory drugsbiological agentstumor necrosis factor-α inhibitorsinterleukin 17/23
spellingShingle O. A. Rumyantseva
Sh. F. Erdes
PROBLEMS IN THE THERAPY OF AXIAL SPONDYLOARTHRITIS IN THE PROCEEDINGS OF THE EULAR CONGRESS 2015 (ROME, 10–13 JUNE 2015)
Научно-практическая ревматология
axial spondyloarthritis
nonsteroidal anti-inflammatory drugs
biological agents
tumor necrosis factor-α inhibitors
interleukin 17/23
title PROBLEMS IN THE THERAPY OF AXIAL SPONDYLOARTHRITIS IN THE PROCEEDINGS OF THE EULAR CONGRESS 2015 (ROME, 10–13 JUNE 2015)
title_full PROBLEMS IN THE THERAPY OF AXIAL SPONDYLOARTHRITIS IN THE PROCEEDINGS OF THE EULAR CONGRESS 2015 (ROME, 10–13 JUNE 2015)
title_fullStr PROBLEMS IN THE THERAPY OF AXIAL SPONDYLOARTHRITIS IN THE PROCEEDINGS OF THE EULAR CONGRESS 2015 (ROME, 10–13 JUNE 2015)
title_full_unstemmed PROBLEMS IN THE THERAPY OF AXIAL SPONDYLOARTHRITIS IN THE PROCEEDINGS OF THE EULAR CONGRESS 2015 (ROME, 10–13 JUNE 2015)
title_short PROBLEMS IN THE THERAPY OF AXIAL SPONDYLOARTHRITIS IN THE PROCEEDINGS OF THE EULAR CONGRESS 2015 (ROME, 10–13 JUNE 2015)
title_sort problems in the therapy of axial spondyloarthritis in the proceedings of the eular congress 2015 rome 10 13 june 2015
topic axial spondyloarthritis
nonsteroidal anti-inflammatory drugs
biological agents
tumor necrosis factor-α inhibitors
interleukin 17/23
url https://rsp.mediar-press.net/rsp/article/view/2259
work_keys_str_mv AT oarumyantseva problemsinthetherapyofaxialspondyloarthritisintheproceedingsoftheeularcongress2015rome1013june2015
AT shferdes problemsinthetherapyofaxialspondyloarthritisintheproceedingsoftheeularcongress2015rome1013june2015